Effect of eicosapentaenoic acid on glucose-induced diacylglycerol synthesis in cultured bovine aortic endothelial cells

被引:23
作者
Kuroki, T [1 ]
Inoguchi, T [1 ]
Umeda, F [1 ]
Nawata, H [1 ]
机构
[1] Kyushu Univ, Fac Med, Dept Internal Med 3, Fukuoka 812, Japan
关键词
eicosapentaenoic acid; diacylglycerol; endothelial cells; high glucose level;
D O I
10.1006/bbrc.1998.8814
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hyperglycemia has been postulated to increase diacylglycerol (DAG) level through de novo synthesis pathway and subsequently activate protein kinase C (PKC) in vascular cells, possibly leading to vascular dysfunction associated with diabetes, In this study, we examined the effect of eicosapentaenoic acid (EPA) on high glucose-induced increase in DAG level in cultured aortic endothelial cells (ECs), In ECs, total DAC; level was significantly increased in the cells cultured with high glucose levels (400 mg/dl) compared with the cells with normal glucose levels (100 mg/dl), The addition of EPA completely prevented high glucose-induced increase in total DAG level. In contrast, other common fatty acids such as palmitate and oleate significantly stimulated DAG; syntheisis, although arachidonate did not affect it. High glucose level significantly stimulated the incorporation of H-3-palmitate into DAG, while it did not affect the incorporation of H-3-arachidonate into DAG;, The addition of EPA completely prevented the high glucose-induced increase in 3H-palmitate incorporation into DAG, while it did not affect the H-3-arachidonate incorporation, These findings suggest that EPA can prevent high glucose induced-increase in DAG: level in ECs, probably by specifically inhibiting de novo synthesis at the step of acylation, EPA may be one of the candidates for clinical agents normalizing activation of DAG-PKC pathway in diabetic vascular tissues and preventing vascular complications associated with diabetes. (C) 1998 Academic Press.
引用
收藏
页码:473 / 477
页数:5
相关论文
共 18 条
[1]   Stimulation of islet protein kinase C translocation by palmitate requires metabolism of the fatty acid [J].
Alcazar, O ;
Zhu, QY ;
Gine, E ;
TamaritRodriguez, J .
DIABETES, 1997, 46 (07) :1153-1158
[2]   PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS [J].
BANG, HO ;
DYERBERG, J ;
NIELSON, AB .
LANCET, 1971, 1 (7710) :1143-&
[3]   PROTEIN KINASE-C IS ACTIVATED IN GLOMERULI FROM STREPTOZOTOCIN DIABETIC RATS - POSSIBLE MEDIATION BY GLUCOSE [J].
CRAVEN, PA ;
DERUBERTIS, FR .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (05) :1667-1675
[4]  
*DCCT RES GROUP, 1993, NEW ENGL J MED, V323, P977
[5]   INSULINS EFFECT ON PROTEIN-KINASE-C AND DIACYLGLYCEROL INDUCED BY DIABETES AND GLUCOSE IN VASCULAR TISSUES [J].
INOGUCHI, T ;
XIA, P ;
KUNISAKI, M ;
HIGASHI, S ;
FEENER, EP ;
KING, GL .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (03) :E369-E379
[6]   PREFERENTIAL ELEVATION OF PROTEIN-KINASE-C ISOFORM-BETA-II AND DIACYLGLYCEROL LEVELS IN THE AORTA AND HEART OF DIABETIC RATS - DIFFERENTIAL REVERSIBILITY TO GLYCEMIC CONTROL BY ISLET CELL TRANSPLANTATION [J].
INOGUCHI, T ;
BATTAN, R ;
HANDLER, E ;
SPORTSMAN, JR ;
HEATH, W ;
KING, GL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) :11059-11063
[7]   ABNORMALITY IN PROSTACYCLIN-STIMULATORY ACTIVITY IN SERA FROM DIABETICS [J].
INOGUCHI, T ;
UMEDA, F ;
ONO, H ;
KUNISAKI, M ;
WATANABE, J ;
NAWATA, H .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (09) :837-842
[8]   Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor [J].
Ishii, H ;
Jirousek, MR ;
Koya, D ;
Takagi, C ;
Xia, P ;
Clermont, A ;
Bursell, SE ;
Kern, TS ;
Ballas, LM ;
Heath, WF ;
Stramm, LE ;
Feener, EP ;
King, GL .
SCIENCE, 1996, 272 (5262) :728-731
[9]  
KING GL, 1990, GROWTH FACTORS HLTH, P308
[10]   Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats [J].
Koya, D ;
Jirousek, MR ;
Lin, YW ;
Ishii, H ;
Kuboki, K ;
King, GL .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (01) :115-126